{"date":"2025-08-05","count":53,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-1813-2025-08-05-2056-9girv7","company_id":"1813","company":"寶利徠","market":"上櫃","industry":"生技醫療","date":"2025-08-05","time":"20:56:25","subject":"依『公開發行公司資金貸與及背書保證處理準則』第二十五條第一項第四款公告","clause":"第22款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：寶利徠（1813），2025-08-05 20:56，「依『公開發行公司資金貸與及背書保證處理準則』第二十五條第一項第四款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1813-2025-08-05-2056-163mvu1","company_id":"1813","company":"寶利徠","market":"上櫃","industry":"生技醫療","date":"2025-08-05","time":"20:56:02","subject":"依『公開發行公司資金貸與及背書保證處理準則』第二十二條第一項第三款公告","clause":"第23款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：寶利徠（1813），2025-08-05 20:56，「依『公開發行公司資金貸與及背書保證處理準則』第二十二條第一項第三款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1813-2025-08-05-2055-aa2zln","company_id":"1813","company":"寶利徠","market":"上櫃","industry":"生技醫療","date":"2025-08-05","time":"20:55:38","subject":"公告本公司董事會通過114年第2季合併財務報告","clause":"第31款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：寶利徠（1813），2025-08-05 20:55，「公告本公司董事會通過114年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2025-08-05-1829-1txcmgc","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2025-08-05","time":"18:29:47","subject":"公告本公司114年度第二季合併財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2025-08-05 18:29，「公告本公司114年度第二季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2025-08-05-1825-1tlpp7s","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2025-08-05","time":"18:25:58","subject":"本公司114年現金增資催繳公告","clause":"第51款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2025-08-05 18:25，「本公司114年現金增資催繳公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2025-08-05-1758-4yzujo","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2025-08-05","time":"17:58:41","subject":"公告本公司訂定除息基準日相關事宜","clause":"第14款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2025-08-05 17:58，「公告本公司訂定除息基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3176-2025-08-05-1757-qmpqzy","company_id":"3176","company":"基亞","market":"上櫃","industry":"生技醫療","date":"2025-08-05","time":"17:57:50","subject":"開發中新藥OBP-301進度更新","clause":"第53款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：基亞（3176），2025-08-05 17:57，「開發中新藥OBP-301進度更新」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6885-2025-08-05-1756-wuph7s","company_id":"6885","company":"全福生技","market":"上市","industry":"生技醫療","date":"2025-08-05","time":"17:56:22","subject":"公告本公司董事會決議通過114年度第二季財務報表","clause":"第31款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：全福生技（6885），2025-08-05 17:56，「公告本公司董事會決議通過114年度第二季財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4120-2025-08-05-1751-87qz4w","company_id":"4120","company":"友華","market":"上櫃","industry":"生技醫療","date":"2025-08-05","time":"17:51:24","subject":"公告本公司114年第二季合併財務報告董事會召開日期","clause":"第31款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：友華（4120），2025-08-05 17:51，「公告本公司114年第二季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6523-2025-08-05-1724-1leasd1","company_id":"6523","company":"達爾膚","market":"上櫃","industry":"生技醫療","date":"2025-08-05","time":"17:24:08","subject":"公告本公司114年第2季合併財務報告之董事會召開日期","clause":"第31款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：達爾膚（6523），2025-08-05 17:24，「公告本公司114年第2季合併財務報告之董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6615-2025-08-05-1721-1j8927m","company_id":"6615","company":"慧智","market":"上櫃","industry":"生技醫療","date":"2025-08-05","time":"17:21:28","subject":"公告本公司114年第2季財務報告董事會預計召開日期為114年08月13日","clause":"第31款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：慧智（6615），2025-08-05 17:21，「公告本公司114年第2季財務報告董事會預計召開日期為114年08月13日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2025-08-05-1720-7pv5tv","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2025-08-05","time":"17:20:48","subject":"本公司民國114年第二季財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2025-08-05 17:20，「本公司民國114年第二季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2025-08-05-1720-rcd28w","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2025-08-05","time":"17:20:32","subject":"公告本公司民國114年第二季合併財務報告董事會召開日期","clause":"第31款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2025-08-05 17:20，「公告本公司民國114年第二季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7808-2025-08-05-1717-jliz4c","company_id":"7808","company":"訊聯智藥","market":"興櫃","industry":"生技醫療","date":"2025-08-05","time":"17:17:48","subject":"(補充公告)本公司董事會通過內部稽核主管異動、設置公司治理主管","clause":"第11款","fact_date":"2025-08-04","cite_as":"公開資訊觀測站重大訊息：訊聯智藥（7808），2025-08-05 17:17，「(補充公告)本公司董事會通過內部稽核主管異動、設置公司治理主管」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3205-2025-08-05-1713-87qz4w","company_id":"3205","company":"佰研","market":"上櫃","industry":"生技醫療","date":"2025-08-05","time":"17:13:56","subject":"公告本公司114年第二季合併財務報告董事會召開日期","clause":"第31款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：佰研（3205），2025-08-05 17:13，「公告本公司114年第二季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6844-2025-08-05-1709-qmmwae","company_id":"6844","company":"諾貝兒","market":"上櫃","industry":"生技醫療","date":"2025-08-05","time":"17:09:46","subject":"公告本公司董事會決議召開114年第一次股東臨時會相關事宜","clause":"第17款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：諾貝兒（6844），2025-08-05 17:09，「公告本公司董事會決議召開114年第一次股東臨時會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6844-2025-08-05-1709-nhbes6","company_id":"6844","company":"諾貝兒","market":"上櫃","industry":"生技醫療","date":"2025-08-05","time":"17:09:07","subject":"公告本公司董事會通過114年第二季個別財務報告","clause":"第31款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：諾貝兒（6844），2025-08-05 17:09，「公告本公司董事會通過114年第二季個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2025-08-05-1650-o0vmsl","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-08-05","time":"16:50:19","subject":"代重要子公司永信藥品工業股份有限公司公告董事會(代行股東會職權)通過解除新任董事競業禁止限制","clause":"第21款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-08-05 16:50，「代重要子公司永信藥品工業股份有限公司公告董事會(代行股東會職權)通過解除新任董事競業禁止限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2025-08-05-1650-16mu1n2","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-08-05","time":"16:50:03","subject":"代重要子公司永信藥品工業股份有限公司公告董事會通過董事長、總經理續任","clause":"第6款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-08-05 16:50，「代重要子公司永信藥品工業股份有限公司公告董事會通過董事長、總經理續任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2025-08-05-1649-140t0j4","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-08-05","time":"16:49:46","subject":"代重要子公司永信藥品工業股份有限公司公告董事會決議114年增資發行新股基準日","clause":"第14款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-08-05 16:49，「代重要子公司永信藥品工業股份有限公司公告董事會決議114年增資發行新股基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2025-08-05-1649-14bnm4x","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-08-05","time":"16:49:29","subject":"代重要子公司永信藥品工業股份有限公司公告董事會重要決議事項","clause":"第51款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-08-05 16:49，「代重要子公司永信藥品工業股份有限公司公告董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6926-2025-08-05-1648-105q0ri","company_id":"6926","company":"聖安生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-05","time":"16:48:07","subject":"公告本公司董事會通過民國114年第二季個別財務報告","clause":"第43款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：聖安生醫（6926），2025-08-05 16:48，「公告本公司董事會通過民國114年第二季個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6850-2025-08-05-1642-o0ne4b","company_id":"6850","company":"光鼎生技","market":"興櫃","industry":"生技醫療","date":"2025-08-05","time":"16:42:17","subject":"公告本公司董事會決議除權息基準日相關事宜","clause":"第31款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：光鼎生技（6850），2025-08-05 16:42，「公告本公司董事會決議除權息基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4109-2025-08-05-1637-1r3zinn","company_id":"4109","company":"加捷生醫","market":"上櫃","industry":"生技醫療","date":"2025-08-05","time":"16:37:18","subject":"公告本公司董事會決議現金股利除息基準日","clause":"第14款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：加捷生醫（4109），2025-08-05 16:37，「公告本公司董事會決議現金股利除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4109-2025-08-05-1637-16ha0nu","company_id":"4109","company":"加捷生醫","market":"上櫃","industry":"生技醫療","date":"2025-08-05","time":"16:37:01","subject":"公告董事會決議設置風險管理委員會及委任成員","clause":"第6款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：加捷生醫（4109），2025-08-05 16:37，「公告董事會決議設置風險管理委員會及委任成員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4109-2025-08-05-1636-gu2xig","company_id":"4109","company":"加捷生醫","market":"上櫃","industry":"生技醫療","date":"2025-08-05","time":"16:36:45","subject":"公告董事會決議設置提名委員會及委任成員","clause":"第6款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：加捷生醫（4109），2025-08-05 16:36，「公告董事會決議設置提名委員會及委任成員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4109-2025-08-05-1636-140kqs7","company_id":"4109","company":"加捷生醫","market":"上櫃","industry":"生技醫療","date":"2025-08-05","time":"16:36:25","subject":"公告本公司董事會通過114年度第二季合併財務報告","clause":"第31款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：加捷生醫（4109），2025-08-05 16:36，「公告本公司董事會通過114年度第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6850-2025-08-05-1635-xyhazt","company_id":"6850","company":"光鼎生技","market":"興櫃","industry":"生技醫療","date":"2025-08-05","time":"16:35:26","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"第43款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：光鼎生技（6850），2025-08-05 16:35，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4126-2025-08-05-1631-1xkemff","company_id":"4126","company":"太醫","market":"上櫃","industry":"生技醫療","date":"2025-08-05","time":"16:31:35","subject":"本公司接獲可成科技(股)公司通知，依據公司法第369條之8規定公告股權變動事宜(取得本公司已發行股份總數超過三分之一以上)","clause":"第33款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：太醫（4126），2025-08-05 16:31，「本公司接獲可成科技(股)公司通知，依據公司法第369條之8規定公告股權變動事宜(取得本公司已發行股份總數超過三分之一以上」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1720-2025-08-05-1631-ggx7gm","company_id":"1720","company":"生達","market":"上市","industry":"生技醫療","date":"2025-08-05","time":"16:31:35","subject":"公告本公司董事會決議通過設立永續發展暨提名委員會及委員名單","clause":"第6款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：生達（1720），2025-08-05 16:31，「公告本公司董事會決議通過設立永續發展暨提名委員會及委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1720-2025-08-05-1631-zaw2nq","company_id":"1720","company":"生達","market":"上市","industry":"生技醫療","date":"2025-08-05","time":"16:31:19","subject":"代子公司「江蘇生達生技醫藥有限公司」公告資金貸與超限改善計畫執行情形","clause":"第51款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：生達（1720），2025-08-05 16:31，「代子公司「江蘇生達生技醫藥有限公司」公告資金貸與超限改善計畫執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1720-2025-08-05-1631-19hlbwf","company_id":"1720","company":"生達","market":"上市","industry":"生技醫療","date":"2025-08-05","time":"16:31:02","subject":"公告董事會通過114年第二季合併財務報告","clause":"第31款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：生達（1720），2025-08-05 16:31，「公告董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6875-2025-08-05-1621-1e4x8h6","company_id":"6875","company":"國邑*","market":"上櫃","industry":"生技醫療","date":"2025-08-05","time":"16:21:25","subject":"公告本公司董事會通過114年第2季財務報表","clause":"第31款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：國邑*（6875），2025-08-05 16:21，「公告本公司董事會通過114年第2季財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6242-2025-08-05-1612-aa2zln","company_id":"6242","company":"立康","market":"上櫃","industry":"生技醫療","date":"2025-08-05","time":"16:12:58","subject":"公告本公司董事會通過114年第2季合併財務報告","clause":"第31款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：立康（6242），2025-08-05 16:12，「公告本公司董事會通過114年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4105-2025-08-05-1611-100esni","company_id":"4105","company":"東洋","market":"上櫃","industry":"生技醫療","date":"2025-08-05","time":"16:11:48","subject":"公告本公司研發主管異動","clause":"第8款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：東洋（4105），2025-08-05 16:11，「公告本公司研發主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4105-2025-08-05-1610-dkx4w4","company_id":"4105","company":"東洋","market":"上櫃","industry":"生技醫療","date":"2025-08-05","time":"16:10:50","subject":"公告本公司114年第2季合併財務報告","clause":"第31款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：東洋（4105），2025-08-05 16:10，「公告本公司114年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2025-08-05-1601-1hkj5dk","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2025-08-05","time":"16:01:32","subject":"係因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2025-08-05 16:01，「係因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6767-2025-08-05-1552-n7r2rh","company_id":"6767","company":"台微醫","market":"上櫃","industry":"生技醫療","date":"2025-08-05","time":"15:52:22","subject":"董事會通過114年第二季合併財務報告","clause":"第31款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：台微醫（6767），2025-08-05 15:52，「董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2025-08-05-1543-6n0ye9","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2025-08-05","time":"15:43:13","subject":"公告本公司訂定114年上半年度現金股利除息基準日相關事宜","clause":"第14款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2025-08-05 15:43，「公告本公司訂定114年上半年度現金股利除息基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2025-08-05-1538-1073yz4","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2025-08-05","time":"15:38:19","subject":"公告本公司董事會決議114年上半年度股利分派","clause":"第14款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2025-08-05 15:38，「公告本公司董事會決議114年上半年度股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2025-08-05-1527-kxgk3x","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2025-08-05","time":"15:27:39","subject":"公告本公司發言人及代理發言人異動","clause":"第8款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2025-08-05 15:27，「公告本公司發言人及代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2025-08-05-1524-xyhazt","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2025-08-05","time":"15:24:06","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"第31款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2025-08-05 15:24，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4911-2025-08-05-1521-1lqlp8o","company_id":"4911","company":"德英","market":"上櫃","industry":"生技醫療","date":"2025-08-05","time":"15:21:17","subject":"公告本公司董事會通過114年度第二季財務報告","clause":"第31款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：德英（4911），2025-08-05 15:21，「公告本公司董事會通過114年度第二季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6918-2025-08-05-1511-tir7kf","company_id":"6918","company":"愛派司","market":"上市","industry":"生技醫療","date":"2025-08-05","time":"15:11:56","subject":"公告本公司114年第二季財務報告董事會預計召開日期為114年8月12日","clause":"第31款","fact_date":"2025-08-04","cite_as":"公開資訊觀測站重大訊息：愛派司（6918），2025-08-05 15:11，「公告本公司114年第二季財務報告董事會預計召開日期為114年8月12日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7829-2025-08-05-1507-87qz4w","company_id":"7829","company":"思捷優達-KY","market":"興櫃","industry":"生技醫療","date":"2025-08-05","time":"15:07:20","subject":"公告本公司114年第二季合併財務報告董事會召開日期","clause":"第44款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：思捷優達-KY（7829），2025-08-05 15:07，「公告本公司114年第二季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6872-2025-08-05-1504-1685kug","company_id":"6872","company":"浩宇生醫","market":"上櫃","industry":"生技醫療","date":"2025-08-05","time":"15:04:42","subject":"公告本公司114年第二季財務報告董事會預計召開日期為114年08月13日","clause":"第31款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：浩宇生醫（6872），2025-08-05 15:04，「公告本公司114年第二季財務報告董事會預計召開日期為114年08月13日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1731-2025-08-05-1502-lr7p8y","company_id":"1731","company":"美吾華","market":"上市","industry":"生技醫療","date":"2025-08-05","time":"15:02:47","subject":"公告本公司114年第二季財務報告董事會預計召開日期為114年8月13日","clause":"第31款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：美吾華（1731），2025-08-05 15:02，「公告本公司114年第二季財務報告董事會預計召開日期為114年8月13日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2025-08-05-1457-dxjj1t","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2025-08-05","time":"14:57:56","subject":"代子公司羅麗芬集團有限公司公告決議配發現金股息之相關事宜","clause":"第14款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2025-08-05 14:57，「代子公司羅麗芬集團有限公司公告決議配發現金股息之相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2025-08-05-1457-ji7jl2","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2025-08-05","time":"14:57:14","subject":"代子公司嘉文麗（福建）化妝品有限公司公告決議配發現金股息之相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2025-08-05 14:57，「代子公司嘉文麗（福建）化妝品有限公司公告決議配發現金股息之相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4142-2025-08-05-1351-5sggiz","company_id":"4142","company":"國光生","market":"上市","industry":"生技醫療","date":"2025-08-05","time":"13:51:11","subject":"本公司受邀參加第一金證券舉辦之法人說明會","clause":"第12款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：國光生（4142），2025-08-05 13:51，「本公司受邀參加第一金證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4168-2025-08-05-1350-1gojerz","company_id":"4168","company":"醣聯","market":"上櫃","industry":"生技醫療","date":"2025-08-05","time":"13:50:20","subject":"公告本公司114年度第二季合併財務報告董事會預計召開日期為114年8月13日","clause":"第31款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：醣聯（4168），2025-08-05 13:50，「公告本公司114年度第二季合併財務報告董事會預計召開日期為114年8月13日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8409-2025-08-05-1342-6pw0xt","company_id":"8409","company":"商之器","market":"上櫃","industry":"生技醫療","date":"2025-08-05","time":"13:42:56","subject":"公告本公司經董事會決議之114年第二季合併財務報告","clause":"第31款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：商之器（8409），2025-08-05 13:42，「公告本公司經董事會決議之114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4133-2025-08-05-1341-ndv213","company_id":"4133","company":"亞諾法","market":"上市","industry":"生技醫療","date":"2025-08-05","time":"13:41:43","subject":"公告本公司114年第2季合併財務報告提案董事會決議預計召開日期為114年08月13日","clause":"第31款","fact_date":"2025-08-05","cite_as":"公開資訊觀測站重大訊息：亞諾法（4133），2025-08-05 13:41，「公告本公司114年第2季合併財務報告提案董事會決議預計召開日期為114年08月13日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}